Form4insider filings, from the source

SEC Form 4 · accession 0001127602-15-009504

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
James F Tessmer
Officer — VP, Finance & Accounting
Period of report
Mar 2, 2015
Accepted (ET)
Mar 3, 2015 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 2, 2015M7,500—A69,141D
Common StockF1Mar 2, 2015M6,750—A75,891D
Common StockF1Mar 2, 2015M6,000—A81,891D
Common StockF1Mar 2, 2015M9,375—A91,266D
Common StockMar 2, 2015F9,041$0.94D82,225D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (Phantom Stock)F1,F3—Mar 2, 2015M7,500D——Common Stock7,5000D
Restricted Stock Units (Phantom Stock)F1,F4—Mar 2, 2015M6,750D——Common Stock6,7506,750D
Restricted Stock Units (Phantom Stock)F1,F5—Mar 2, 2015M6,000D——Common Stock6,00012,000D
Restricted Stock Units (Phantom Stock)F1,F6—Mar 2, 2015M9,375D——Common Stock9,37528,125D

Explanation of responses